Clinical Trials Directory

Trials / Recruiting

RecruitingNCT06778174

Prospective Analysis of the Treatment of Progressive Familial Intrahepatic Cholestasis (TreatFIC)

Status
Recruiting
Phase
Study type
Observational
Enrollment
200 (estimated)
Sponsor
University Medical Center Groningen · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

The project has the following general aims: 1. Natural course and prognosis: To prospectively follow the natural course and prognosis of the different types of PFIC, to broaden the understanding of the different very rare diseases and to allow predictions about the course of disease in different types of PFIC. 2. Efficacy: To define the course of disease in FIC patients and identify associations with different treatments (symptomatic treatments, interruption of the enterohepatic circulation by surgical or medical means and other therapies such as corrector/potentiator or exon skipping therapy. The course of disease will be characterized by biochemical, clinical and surgical parameters, including liver transplantation. 3. Safety: To define the complications associated with the different treatments (symptomatic treatments, interruption of the enterohepatic circulation by surgical or medical means and other therapies such as corrector/potentiator or exon skipping therapy, liver transplantation). Follow up will be as long as possible. 4. (Surrogate) biomarker response: Biochemical parameters will be longitudinally collected and associated with changes in treatments / course of disease. 5. Genotype-phenotype relationships: If patient numbers permit, to establish genotype-phenotype relationships for (non)responsiveness towards different treatments in patients with genetic mutations causing the different forms of FIC disease.

Conditions

Interventions

TypeNameDescription
OTHERobservational studyThe interventions are not determined by the study, which is purely observational on "real world data".

Timeline

Start date
2023-02-09
Primary completion
2028-02-01
Completion
2033-12-01
First posted
2025-01-16
Last updated
2025-01-24

Locations

1 site across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT06778174. Inclusion in this directory is not an endorsement.